Recall report: More Chantix lots pulled from shelves as nitrosamine woes continue
Another four lots of Pfizer’s popular anti-smoking drug have been recalled due to high levels of nitrosamine, the FDA announced.
Pifzer halted distribution of Chantix and recalled four lots of the drug in June, after finding elevated levels of cancer-causing nitrosamines. Despite the recall, an official at Pfizer Korea said the company believes the benefits of the non-smoking drug outweigh any potential risk of exposure to nitrosamines, and that those who have been taking it should continue to do so.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.